Sasol Won't Pay Final Dividend on High Debt
By Nina Kienle
Sasol said it won't pay a final dividend for fiscal 2024, citing high debt levels, and reported a swing to a net loss amid challenging market conditions.
The South African chemical and energy company on Tuesday said a disconnect between headline earnings and cash-flow generation, as well as high debt levels, led to a revision to its dividend policy.
The new policy is based on 30% of free cash flow generated provided that net debt excluding leases is below $4 billion on a sustained basis, but the company ended fiscal 2024 with net debt of $4.1 billion. As a result, the company didn't declare a final dividend for the year.
Sasol had paid a dividend of 2.00 South African rand for the first six months of the year. For fiscal 2023 as a whole, the company paid out total dividends of 17 South African rand a share.
Headline earnings dropped 66% to 11.51 billion South African rand ($650.1 million) and turnover fell 5% to 275.1 billion South African rand for the fiscal year ended June 30.
The company posted a net loss of 44.27 billion South African rand compared with a profit of 8.80 billion South African rand a year before. Sasol had previously said its fiscal 2024 results would take a hit from impairments on chemicals and fuel assets, mainly due to weak prices.
Write to Nina Kienle at nina.kienle@wsj.com
(END) Dow Jones Newswires
August 20, 2024 03:05 ET (07:05 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
What’s the Difference Between the CPI and PCE Indexes?
-
Micron Earnings: Great Guidance but Stock Now Looks Fairly Valued
-
August PCE Report Forecasts Show More Good News on Inflation
-
AI Stocks May Be Down, but Don’t Count Them Out
-
4 Stocks to Buy as the Fed Cuts Interest Rates
-
Markets Brief: The Uncertain Path to Neutral Interest Rates
-
What’s Happening in the Markets This Week
-
Where Top Stock Fund Managers Are Looking Next After the Fed Rate Cut
-
Our Top Pick for Investing in US Renewable Energy
-
Undervalued by 25% and Yielding 5%, This Stock Is a Buy
-
Can AI Predict Future Stock Returns?
-
The Best Energy Stocks to Buy Now
-
10 Undervalued Wide-Moat Stocks
-
Obesity Drugs: Can New Firms Take Market Share From Eli Lilly and Novo Nordisk?
-
New 4-Star Stocks
-
Intel Fair Value Left Unchanged Despite Qualcomm Takeover Talk